alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[PORTIONS OF THIS EXHIBIT HAVE BEEN REDACTED PURSUANT TO A REQUEST FOR
CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION.]

                                  APPENDIX A-1

                                    PRODUCTS


Product Name:     AB KING PRO

Product Description: Fitness Machine to exercise abdominal muscles

Projected Units Sold next 24 months: XXXXXX

Manufacturer:     CirTran-Asia

Sub-Manufacturer: XXXXXX (SHENZHEN - CHINA) INTERNATIONAL
                           XXXXXX (SHENZHEN - CHINA) - USA-DOMESTIC

Marketing Partner Contact Info:


Current Sale Price: $XXXXXX USD - (USA-DOMESTIC) - XXXXX
                    $XXXXXX USD - (INTERNATIONAL) - XXXXX


Current Cost to Manufacturer:       $XXXXXX INTERNATIONAL
                                    $XXXXXX RETAIL
                                    $XXXXXX No-TAPES
                                    $XXXXXX XXXXXX

Total Tooling/Development Costs:    $162,199.84

Profit Per Unit for International Sales (XXXXX ORDERS)  ($XXXXXX) Profit

CirTran-Asia      $XXXXXXUSD
XXXXXX            $XXXXXXUSD
XXXXXX            $XXXXXXUSD
XXXXXX            $XXXXXXUSD

Profit Per Unit for Domestic Sales (XXXXXX) ($XXXXXX) Profit

CirTran-Asia      $XXXXXXUSD
XXXXXX            $XXXXXXUSD
XXXXXX            $XXXXXXUSD
XXXXXX            $XXXXXXUSD


AB KING Stock Option Schedule
<PAGE>

Upon full execution of this Agreement, CirTran's parent CirTran Corporation will
issue the following options to purchase restricted common stock:

                           Michael Casey             500,000 shares
                           David Hayek               500,000 shares
                           Charles Ho                500,000 shares

These initial options will vest and be exercisable only after CirTran has sold,
shipped and received payments for 200,000 AB KING units. The options will be
exercisable at $.06 per share (the current market price) after vesting. The
options will expire and will no longer be exercisable on the date one year after
the date hereof.

In addition, for each whole multiple of 100,000 AB KING units sold by CirTran
during the first 24 months of this Agreement in excess of the initial 200,000
units, CirTran Corporation will grant each of Michael Casey, David Hayek and
Charles Ho an option to purchase 100,000 shares. Each such additional option
will be exercisable for a period of 12 months at an exercise price equal to the
fair market value of CirTran Corporation stock on the date of grant (i.e. the
mean between the high bid and low asked prices for the stock for the date of
determination).

As a condition to grant of the options, each option holder will be required to
make standard investment representations to CirTran Corporation.

[XXXXX - REDACTED PURSUANT TO REQUEST FOR CONFIDENTIAL TREATMENT AND FILED
SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.]
###### Editorial Note on Part 170

#### Editorial Note:

Nomenclature changes to part 170 appear at 66 FR 56035, Nov. 6, 2001, and 69 FR 13717, Mar. 24, 2004.

#### § 170.245 Part 5 of a GRAS notice: Experience based on common use in food before 1958.

If the statutory basis for your conclusion of GRAS status is through experience based on common use in food, in Part 5 of your GRAS notice you must include evidence of a substantial history of consumption of the notified substance for food use by a significant number of consumers prior to January 1, 1958.
* Pursuant to 5 TH C IR

. R. 47.5, the Court has determined that this opinion shoul d not be

published and is not precedent except under the limit ed circumstances set forth in 5 TH C IR

. R. 47.5.4. UNITED STATES COURT OF APPEALS FOR THE FIFTH CIRCUIT

______________________ No. 99-50458

______________________ THE UNITED STATES OF AMERICA FOR THE USE AND BENEFIT OF STEVE WIMBERLY, doing business as

Wimberly Erection Company, Plaintiff-Appellant,

versus TIPS IRON & STEEL CO., INC., ET AL. Defendants, BUFETE INDUSTRIAL, INC.; H J GROUP VENTURES, INC.; BUFETE INDUSTRIAL, INC./H J GROUP VENTURES, INC., a Joint Venture; FEDERAL INSURANCE COMPANY, Defendants-Appellees.

_________________________________________ Appeal from the United States District Court for the Western District of Texas (W-98-CV-73)

_________________________________________

February 4, 2000 Before BARKSDALE, BENAVIDES, and STEWART, Circuit Judges. PER CURIAM: *

AFFIRMED. See 5 TH

C IR . R. 47.6.
#### § 250.105 Gelsemium-containing preparations regarded as prescription drugs.

It is the consensus of informed medical opinion that the margin of safety between the therapeutic and toxic concentration of gelsemium is narrow and it is difficult to predict the point at which the dose will be toxic. Very small doses may cause toxic symptoms. It is therefore the view of the Food and Drug Administration that gelsemium is not a proper ingredient in any product that is to be sold without prescription. Accordingly, any drug containing gelsemium will be regarded as misbranded under section 503(b)(4) of the Federal Food, Drug, and Cosmetic Act if its label fails to bear in a prominent and conspicuous fashion the statement “Rx only.”

[40 FR 14033, Mar. 27, 1975, as amended at 67 FR 4906, Feb. 1, 2002]
§ 1003.21 Notification by the manufacturer to affected persons. ( a ) The notification to the persons specified in § 1003.10(b) shall be in writing and, in addition to other relevant information which the Secretary may require, shall include: ( 1 ) The information prescribed by § 1003.20 (a), (d), and instructions with respect to the use of the product pending the correction of the defect;
( 2 ) A clear evaluation in nontechnical terms of the hazards reasonably related to any defect or failure to comply; and
( 3 ) The following statement: The manufacturer will, without charge, remedy the defect or bring the product into compliance with each applicable Federal standard in accordance with a plan to be approved by the Secretary of Health and Human Services, the details of which will be included in a subsequent communication to you.
*Provided,* That if at the time the notification is sent, the Secretary has approved a plan for the repair, replacement or refund of the product, the notification may include the details of the approved plan in lieu of the above statement.
( b ) The envelope containing the notice shall not contain advertising or other extraneous material, and such mailings will be made in accordance with this section. ( 1 ) No. 10 white envelopes shall be used, and the name and address of the manufacturer shall appear in the upper left corner of the envelope.
( 2 ) The following statement is to appear in the far left third of the envelope in the type and size indicated and in reverse printing, centered in a red rectangle 33 ⁄ 4 inches wide and 21 ⁄ 4 inches high: Important—Electronic Product Radiation Warning The statement shall be in three lines, all capitals, and centered. “Important” shall be in 36-point Gothic Bold type. “Electronic Product” and “Radiation Warning” shall be in 36-point Gothic Condensed type.
( 3 ) Envelopes with markings similar to those prescribed in this section shall not be used by manufacturers for mailings other than those required by this part.
( c ) The notification shall be sent: ( 1 ) By certified mail to purchasers of the product and to subsequent transferees.
( 2 ) By certified mail or other more expeditious means to dealers and distributors.
( d ) Where products were sold under a name other than that of the manufacturer of the product, the name of the individual or company under whose name the product was sold may be used in the notification required by this section.
H. R. 7218 

One Hundred Eighteenth Congress 

of the 

United States of America 

AT THE SECOND SESSION 

Begun and held at the City of Washington on Wednesday, 

the third day of January, two thousand and twenty-four 

An Act 

To amend title III of the Public Health Service Act to extend the program for 

promotion of public health knowledge and awareness of Alzheimer’s disease and 

related dementias, and for other purposes. 

Be it enacted by the Senate and House of Representatives of 

the United States of America in Congress assembled, 

SECTION 1. SHORT TITLE. 

This Act may be cited as the ‘‘BOLD Infrastructure for 

Alzheimer’s Reauthorization Act of 2024’’. 

SEC. 2. EXTENSION OF PROGRAM FOR PROMOTION OF PUBLIC HEALTH 

KNOWLEDGE AND AWARENESS OF ALZHEIMER’S DISEASE 

AND RELATED DEMENTIAS. 

Section 398B(e) of the Public Health Service Act (42 U.S.C. 

280c–5(e)) is amended by inserting ‘‘and $33,000,000 for each of 

fiscal years 2025 through 2029’’ before the period at the end. 

Speaker of the House of Representatives. 

Vice President of the United States and

President of the Senate.
Editorial Note on Part 177
Editorial Note: Nomenclature changes to part 177 appear at 61 FR 14482, Apr. 2, 1996; 66 FR 56035, Nov. 6, 2001; 66 FR 66742, Dec. 27, 2001; 68 FR 15355, Mar. 31, 2003; 70 FR 72074, Dec. 1, 2005; and 81 FR 49896, July 29, 2016.

§ 177.1420 Isobutylene polymers. Isobutylene polymers may be safely used as components of articles intended for use in producing, manufacturing, packing, processing, preparing, treating, packaging, transporting, or holding food, in accordance with the following prescribed conditions: ( a ) For the purpose of this section, isobutylene polymers are those produced as follows: ( 1 ) Polyisobutylene produced by the homopolymerization of isobutylene such that the finished polymers have a molecular weight of 750,000 (Flory) or higher.
( 2 ) Isobutylene-isoprene copolymers produced by the copolymerization of isobutylene with not more than 3 molar percent of isoprene such that the finished polymers have a molecular weight of 300,000 (Flory) or higher.
( 3 ) Chlorinated isobutylene-isoprene copolymers produced when isobutylene-isoprene copolymers (molecular weight 300,000 (Flory) or higher) are modified by chlorination with not more than 1.3 weight-percent of chlorine.
( b ) The polymers identified in paragraph (a) of this section may contain optional adjuvant substances required in the production of the polymers. The optional adjuvant substances required in the production of the polymers may include substances generally recognized as safe in food, substances used in accordance with a prior sanction or approval, and aluminum chloride.
( c ) The provisions of this section are not applicable to polyisobutylene used in food-packaging adhesives complying with § 175.105 of this chapter.
<PAGE>
                                                                   Exhibit 99.10

                         AMCOL INTERNATIONAL CORPORATION

                   Certification of Periodic Financial Report
                       Pursuant to 18 U.S.C. Section 1350

     Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of
the Sarbanes-Oxley Act of 2002, the undersigned officer of AMCOL International
Corporation (the "Company") certifies that the Quarterly Report on Form 10-Q of
the Company for the quarter ended June 30, 2002 fully complies with the
requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934
and information contained in that Form 10-Q fairly presents, in all material
respects, the financial condition and results of operations of the Company.


Dated: August 12, 2002                                   /s/ Gary L. Castagna
                                                         -----------------------
                                                         Gary L. Castagna
                                                         Chief Financial Officer

<PAGE>

                         AMCOL INTERNATIONAL CORPORATION

                   Certification of Periodic Financial Report
                       Pursuant to 18 U.S.C. Section 1350

     Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of
the Sarbanes-Oxley Act of 2002, the undersigned officer of AMCOL International
Corporation (the "Company") certifies that the Quarterly Report on Form 10-Q of
the Company for the quarter ended June 30, 2002 fully complies with the
requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934
and information contained in that Form 10-Q fairly presents, in all material
respects, the financial condition and results of operations of the Company.


Dated: August 12, 2002                                   /s/ Lawrence E. Washow
                                                         -----------------------
                                                         Lawrence E. Washow
                                                         Chief Executive Officer
<PAGE>   1
                                                                   Exhibit 23(b)

             CONSENT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS

We hereby consent to the incorporation by reference in the Registration
Statement on Form S-3 (No. 333-80147), as supplemented by the Prospectus dated
June 22, 1999 and the Prospectus Supplement dated June 23, 1999, of our report
dated January 17, 1997 relating to the financial statements, which appears in
Aristar, Inc.'s Annual Report on Form 10-K for the year ended December 31,
1998. We also consent to the reference to us under the heading "Experts" in
such Registration Statement.

/s/ PricewaterhouseCoopers LLP

PricewaterhouseCoopers LLP
Tampa, Florida
June 23, 1999
Table of Contents
Exhibit
10.10.3

Amendment Number 2 to
Employment Agreement dated
as of January 1, 2004
Between Ormat Nevada Inc and Yeheskel Ram
(the Employment Agreement)

Entered this 4 day of June
2006

The Employment Agreement is hereby amended as
follows:

Section 7.2 is being replaced in its entirety by
the following Section 7.2.


Termination by Employee
- In case of termination of Employee's employment by Employee,
Employee shall be entitled to received Employee's monthly salary
during the 90 days period specified in paragraph 6.3, provided,
however, that if Employee requests to shorten the 90 days notice
period, Employee shall not be entitled to receive any payments for
services for the period beyond the date services are provided.

All other terms of the Employment Agreement remain
unchanged.

IN WITNESS WHEREOF, the parties have executed
and entered into this Employment Agreement on the date set forth
above.


		EMPLOYEE





		   /s/
Yeheskel Ram                                





		EMPLOYER





		By:    Yehudit
Bronicki

/s/      Yehudit
Bronicki

Its:    President
Exhibit 21.1

Subsidiaries (all are 100% owned)

Name                                         Jurisdiction
----                                         ------------

Level 8 Technologies, Inc.                   Delaware

Cicero Technologies, Inc                     Delaware

Template Software de Mexico, S.A. de C.V.    Mexico

Template Software Pty Ltd.                   Australia

Template Software Holding GmbH               Germany

  Template SoftwareGeschaftsfuhrungs GmbH    Germany

  Template Software GmbH                     Germany

Level 8 Worldwide Holdings Ltd.              Delaware

  Seer Technologies de Argentina S.A         Argentina

  Level 8 FSC, Inc.                          Barbados

  Level 8 Benelux B.V                        Netherlands

  Seer Technologies do Brasil Ltda           Brazil

  Level 8 Canada, Inc.                       Canada

  Level 8 Europe (Deutschland) GmbH          Germany

  Level 8 Ireland Limited                    Ireland

  Level 8 Italia S.R.L.                      Italy

  Level 8 Systems Nordic AB                  Sweden

  Seer Korea Co., Limited                    Korea

  Seer Technologies Singapore PTY, Limited   Singapore

  Seer Technologies Hong Kong Limited        Hong Kong

3020126 Canada, Inc. (fka Bizware)           Canada


                                      E-76
Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Small Business Administration [Disaster Declaration #12036 and #12037]
 AGENCY: U.S. Small Business Administration.
 ACTION: Notice.
 SUMMARY: This is a Notice of the Presidential declaration of a major disaster for Public Assistance Only for the State of New Jersey (FEMA-1873-DR), dated 02/05/2010. *Incident:*
                         Snowstorm. *Incident Period:*
                         12/19/2009 through 12/20/2009. *Effective Date:*
                         02/05/2010.
                        ( print page 7637) *Physical Loan Application Deadline Date:*
                         04/06/2010. *Economic Injury (EIDL) Loan Application Deadline Date:*
                         11/05/2010.
 ADDRESSES: Submit completed loan applications to: U.S. Small Business Administration, Processing and Disbursement Center, 14925 Kingsport Road, Fort Worth, TX 76155.
 FOR FURTHER INFORMATION CONTACT: A. Escobar, Office of Disaster Assistance, U.S. Small Business Administration, 409 3rd Street, SW., Suite 6050, Washington, DC 20416.


SUPPLEMENTARY INFORMATION: Notice is hereby given that as a result of the President's major disaster declaration on 02/05/2010, Private Non-Profit organizations that provide essential services of governmental nature may file disaster loan applications at the address listed above or other locally announced locations. The following areas have been determined to be adversely affected by the disaster: *Primary Counties:*
                     Atlantic, Burlington, Camden, Cumberland, Gloucester, Ocean, Salem. *The Interest Rates are:* Percent*For Physical Damage:**Non-Profit Organizations With Credit Available Elsewhere*
3.625*Non-Profit Organizations With Credit Available Elsewhere*
3.000*For Economic Injury:**Non-Profit Organizations With Credit Available Elsewhere*
3.000
 The number assigned to this disaster for physical damage is 12036B and for economic injury is 12037B. (Catalog of Federal Domestic Assistance Numbers 59002 and 59008) James E. Rivera, Associate Administrator for Disaster Assistance.


[FR Doc. 2010-3315 Filed 2-19-10; 8:45 am] BILLING CODE 8025-01-P
# L_2018286EN.01000101.xml

| 14.11.2018 | EN | Official Journal of the European Union | L 286/1 |
| --- | --- | --- | --- |

14.11.2018

EN

Official Journal of the European Union

L 286/1

---

COMMISSION IMPLEMENTING REGULATION (EU) 2018/1708

of 13 November 2018

conferring protection under Article 99 of Regulation (EU) No 1308/2013 of the European Parliament and of the Council on the name ‘Însurăței’ (PDO)

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EU) No 1308/2013 of the European Parliament and of the Council of 17 December 2013 establishing a common organisation of the markets in agricultural products and repealing Council Regulations (EEC) No 922/72, (EEC) No 234/79, (EC) No 1037/2001 and (EC) No 1234/2007 (1), and in particular Article 99 thereof,

Whereas:

| (1) | In accordance with Article 97(2) and (3) of Regulation (EU) No 1308/2013, the Commission examined Romania's application to register the name ‘Însurăței’ and published it in the Official Journal of European Union (2). |
| --- | --- |

(1)

In accordance with Article 97(2) and (3) of Regulation (EU) No 1308/2013, the Commission examined Romania's application to register the name ‘Însurăței’ and published it in the Official Journal of European Union (2).

| (2) | No statement of objection has been received by the Commission under Article 98 of Regulation (EU) No 1308/2013. |
| --- | --- |

(2)

No statement of objection has been received by the Commission under Article 98 of Regulation (EU) No 1308/2013.

| (3) | In accordance with Article 99 of Regulation (EU) No 1308/2013, the name ‘Însurăței’ should be protected and entered in the register referred to in Article 104 of that Regulation. |
| --- | --- |

(3)

In accordance with Article 99 of Regulation (EU) No 1308/2013, the name ‘Însurăței’ should be protected and entered in the register referred to in Article 104 of that Regulation.

| (4) | The measures provided for in this Regulation are in accordance with the opinion of the Committee for the Common Organisation of Agricultural Markets, |
| --- | --- |

(4)

The measures provided for in this Regulation are in accordance with the opinion of the Committee for the Common Organisation of Agricultural Markets,

HAS ADOPTED THIS REGULATION:

Article 1

The name ‘Însurăței’ (PDO) is hereby protected.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 13 November 2018.

For the Commission

The President

Jean-Claude JUNCKER

---

(1)  
  OJ L 347, 20.12.2013, p. 671.

1

(2)  
  OJ C 144, 25.4.2018, p. 2.

2

---
<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
     (Replace this text with the legend)
</LEGEND>
<CIK>                         0000813621
<NAME>                        AMCOL INTERNATIONAL CORPORATION
<MULTIPLIER>                                   1,000
<CURRENCY>                                     USD
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                              DEC-31-1997
<PERIOD-START>                                 APR-1-1997
<PERIOD-END>                                   JUN-30-1997
<EXCHANGE-RATE>                                1.00
<CASH>                                         4,177
<SECURITIES>                                   0
<RECEIVABLES>                                  80,549
<ALLOWANCES>                                   2,179
<INVENTORY>                                    58,454
<CURRENT-ASSETS>                               149,526
<PP&E>                                         308,167
<DEPRECIATION>                                 129,919
<TOTAL-ASSETS>                                 348,143
<CURRENT-LIABILITIES>                          60,546
<BONDS>                                        0
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                    0
<COMMON>                                       213
<OTHER-SE>                                     0
<TOTAL-LIABILITY-AND-EQUITY>                   348,143
<SALES>                                        221,408
<TOTAL-REVENUES>                               221,408
<CGS>                                          175,894
<TOTAL-COSTS>                                  204,638
<OTHER-EXPENSES>                               580
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             4,360
<INCOME-PRETAX>                                11,830
<INCOME-TAX>                                   4,375
<INCOME-CONTINUING>                            7,455
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   7,455
<EPS-PRIMARY>                                  .38
<EPS-DILUTED>                                  .38
        


</TABLE>